Fig. 9

Clinical correlation analysis. A–D Risk scores were significantly differentially expressed at different pathological stages. E–G The CD24 gene was significantly associated with the pathological stage, T-stage, and N-stage of patients. H, I CAV1 expression was significantly associated with the pathological stage and T-stage of thyroid cancer patients. J TACC1 expression was significantly associated with the M-stage of thyroid cancer patients. K, L TIPARP expression was significantly associated with the pathological stage and N-stage of thyroid cancer patients. M–O HSD17B10 expression was significantly associated with the M-stage of thyroid cancer patients. Significant differences were found between the different pathological stages, T-stage, and N-stage of thyroid cancer patients; no significant differences in the M-stage were observed